Nicolet Advisory Services’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$27K	Hold	16,000	–	–	﹤0.01%	407
2025 Q1	$29.1K	Hold	16,000	–	–	﹤0.01%	379
2024 Q4	$24.8K	Buy	+16,000	New	+$24.8K	﹤0.01%	380